Stéphane Breault1, Francesco Doenz2, Anne-Marie Jouannic2, Salah Dine Qanadli2. 1. Diagnostic and Interventional Radiology Department, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 21, Lausanne, CH-1011, Switzerland. stephane.breault.1@umontreal.ca. 2. Diagnostic and Interventional Radiology Department, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 21, Lausanne, CH-1011, Switzerland.
Abstract
BACKGROUND: The vast majority of superior vena cava (SVC) syndromes are of malignant causes, but with growing use of indwelling central catheters and implanted cardiac devices, benign SVC syndromes are becoming more frequent. The main objective of this study is to evaluate long term outcome in patients treated for benign SVC syndrome by endovascular techniques. METHODS: Forty-four patients, 26 men and 18 women, mean age 56, treated for benign SVC syndrome using endovascular techniques between 2002 and 2015 were included. Type of obstruction was classified according to the site of disease and degree of occlusion. Complications and recurrence of symptoms were analyzed. RESULTS: Technical and clinical success were achieved in all but one patient. Four patients (9 %) were treated by angioplasty alone and 40 (91 %) required stent implantation. Mean clinical follow-up was 1275 days. Nine patients had at least one episode of recurrence after a mean of 385 days. Four minor and two major complications were reported. CONCLUSION: Percutaneous endovascular techniques to treat benign SVC syndrome are safe with good long term patency. Recurrence of symptoms can easily be addressed by repeat procedure. KEY POINTS: • Malposition of indwelling central catheter can cause superior vena cava obstruction. • Image-guided catheter placement helps prevent superior vena cava obstruction. • Imaging and superior vena cava obstruction classification allows adequate procedure planning. • Endovascular techniques are safe and effective for superior vena cava syndrome treatment.
BACKGROUND: The vast majority of superior vena cava (SVC) syndromes are of malignant causes, but with growing use of indwelling central catheters and implanted cardiac devices, benign SVC syndromes are becoming more frequent. The main objective of this study is to evaluate long term outcome in patients treated for benign SVC syndrome by endovascular techniques. METHODS: Forty-four patients, 26 men and 18 women, mean age 56, treated for benign SVC syndrome using endovascular techniques between 2002 and 2015 were included. Type of obstruction was classified according to the site of disease and degree of occlusion. Complications and recurrence of symptoms were analyzed. RESULTS: Technical and clinical success were achieved in all but one patient. Four patients (9 %) were treated by angioplasty alone and 40 (91 %) required stent implantation. Mean clinical follow-up was 1275 days. Nine patients had at least one episode of recurrence after a mean of 385 days. Four minor and two major complications were reported. CONCLUSION: Percutaneous endovascular techniques to treat benign SVC syndrome are safe with good long term patency. Recurrence of symptoms can easily be addressed by repeat procedure. KEY POINTS: • Malposition of indwelling central catheter can cause superior vena cava obstruction. • Image-guided catheter placement helps prevent superior vena cava obstruction. • Imaging and superior vena cava obstruction classification allows adequate procedure planning. • Endovascular techniques are safe and effective for superior vena cava syndrome treatment.
Authors: Bruno Scheller; Christoph Hehrlein; Wolfgang Bocksch; Wolfgang Rutsch; Dariush Haghi; Ulrich Dietz; Michael Böhm; Ulrich Speck Journal: N Engl J Med Date: 2006-11-13 Impact factor: 91.245
Authors: S D Qanadli; M El Hajjam; F Mignon; E de Kerviler; P Rocha; O Barré; S Chagnon; P Lacombe Journal: AJR Am J Roentgenol Date: 1999-07 Impact factor: 3.959
Authors: Grzegorz Rozmus; James P Daubert; David T Huang; Spencer Rosero; Burr Hall; Charles Francis Journal: J Interv Card Electrophysiol Date: 2005-06 Impact factor: 1.900
Authors: T Smayra; P Otal; V Chabbert; P Chemla; M Romero; F Joffre; H Rousseau Journal: Cardiovasc Intervent Radiol Date: 2001-10-17 Impact factor: 2.740
Authors: Jo Caers; Christel Fontaine; Vincent Vinh-Hung; Johan De Mey; Gerrit Ponnet; Chris Oost; Jan Lamote; Jacques De Greve; Benjamin Van Camp; Patrick Lacor Journal: Support Care Cancer Date: 2004-11-05 Impact factor: 3.603
Authors: Susanne Anton; T Oechtering; E Stahlberg; F Jacob; M Kleemann; J Barkhausen; J P Goltz Journal: Support Care Cancer Date: 2017-12-22 Impact factor: 3.603
Authors: Mustafa M Haddad; Benjamin Simmons; Ian R McPhail; Manju Kalra; Melissa J Neisen; Matthew P Johnson; Andrew H Stockland; James C Andrews; Sanjay Misra; Haraldur Bjarnason Journal: Cardiovasc Intervent Radiol Date: 2018-02-28 Impact factor: 2.740